Retinal diseases: Groundbreaking gene therapy offers hope to 5 million
Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream, is now emerging as
Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream, is now emerging as
Andrew Campbell, MD, is a distinguished leader in the field of sickle cell disease research and treatment. Currently serving as the director of the Comprehensive